Aon

Aon's analysis highlights a moderation in medical and pharmacy claim cost growth, particularly with GLP-1 medications, demonstrating their impact on employer healthcare expenditures. The firm quantifies the financial implications of new pharmaceutical classes, leveraging proprietary data to advise clients on evolving healthcare risks and benefit program optimization. This focus on translating clinical trends into actionable financial strategies remains central to their risk and people advisory services.

The company is also emphasizing the strategic integration of AI, cautioning that prioritizing automation over adaptability and change management skills risks limiting AI's full potential. This dual focus on managing healthcare costs and strategically integrating AI reflects Aon's evolving advisory posture, aiming to optimize benefits design and control long-term liabilities while ensuring technological advancements are human-centric.

Further insights from Aon indicate that many employers struggle to effectively communicate their pay decisions to employees. This challenge, coupled with a lack of comprehensive pay remediation analyses, suggests a gap in how organizations manage compensation strategies. Aon's work in this area underscores its commitment to providing guidance on complex human capital issues beyond healthcare and technology.

Last updated September 20, 2026